Ascend Wellness (OTC:AAWH) Upgraded by Zacks Research to "Strong Sell" Rating

Key Points

• Ascend Wellness (OTC:AAWH) has been downgraded to a "strong sell" rating by analysts at Zacks Research, as reported in a recent research report.
• The company's stock opened at $0.64, with a market cap of approximately $130.84 million and a significant decline reflected in its P/E ratio of -1.56.
• Ascend Wellness engages in the cultivation and distribution of various cannabis products, including flower, concentrates, and edibles, under multiple brand names.

Zacks Research upgraded shares of Ascend Wellness (OTC:AAWH - Free Report) to a strong sell rating in a research note released on Tuesday morning,Zacks.com reports.

Ascend Wellness Price Performance

AAWH traded up $0.02 during trading on Tuesday, reaching $0.67. The stock had a trading volume of 594,821 shares, compared to its average volume of 139,724. The stock has a market cap of $136.81 million, a PE ratio of -1.63 and a beta of 1.04. The company has a debt-to-equity ratio of 2.61, a quick ratio of 0.80 and a current ratio of 1.47. Ascend Wellness has a one year low of $0.26 and a one year high of $1.23. The business has a 50-day moving average of $0.40 and a 200-day moving average of $0.37.

About Ascend Wellness

Ascend Wellness Holdings, Inc engages in the cultivation, manufacture, and distribution of cannabis consumer packaged goods in the United States. The company offers flower, pre-rolls, concentrates, vapes, edibles, tinctures, and other cannabis-related products under the Common Goods, SimplyHerb, Ozone, Ozone Reserve, Royale, Tunnel Vision, Miss Grass, Lowell Smokes, Edie Parker, 1906, and AiroPro brands.